Bartsch R, Berghoff AS, Furtner J, Marhold M, et al. FINAL outcome ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-positive breast cancer PATIENTS WITH active brain metastases. Neuro Oncol 2024 Jul 4:noae123. doi: 10.1093.
PMID: 38963808